CHING-WEI DAVID TZENG to Safety
This is a "connection" page, showing publications CHING-WEI DAVID TZENG has written about Safety.
Connection Strength
0.042
-
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases. Clin Cancer Res. 2021 06 01; 27(11):3039-3049.
Score: 0.042